Fabrazyme 5 mg/mL
AGALSIDASE BETA · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Genzyme Corporation
Fabrazyme is a injection, powder, lyophilized, for solution containing agalsidase beta at 5 mg/mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- Fabrazyme
- Generic Name
- AGALSIDASE BETA
- NDC Code (Product)
58468-0041- Manufacturer
- Genzyme Corporation
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA103979
- Drug Class
- Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
- Marketing Start
- 12/17/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is Fabrazyme used for?
Fabrazyme contains AGALSIDASE BETA. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Fabrazyme a controlled substance?
Fabrazyme is not classified as a controlled substance by the DEA.
What is the generic name for Fabrazyme?
The generic name for Fabrazyme is AGALSIDASE BETA. There are no other listed brand versions of AGALSIDASE BETA.
What is the NDC code for Fabrazyme 5 mg/mL?
The NDC (National Drug Code) for Fabrazyme 5 mg/mL is 58468-0041, listed by Genzyme Corporation.
Other Fabrazyme Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)